|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/42 | |
| A61K 39/21 | |||
| C12N 5/07 |
| (11) | Number of the document | 3052132 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14847004.0 |
| Date of filing the European patent application | 2014-09-30 | |
| (97) | Date of publication of the European application | 2016-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/058383 |
| Date | 2014-09-30 |
| (87) | Number | WO 2015/048770 |
| Date | 2015-04-02 |
| (30) | Number | Date | Country code |
| 201361884414 P | 2013-09-30 | US |
| (72) |
BAROUCH, Dan, H., US
|
| (73) |
Beth Israel Deaconess Medical Center, Inc.,
330 Brookline Avenue, Boston, MA 02215,
US
|
| (54) | ANTIBODY THERAPIES FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) |
| ANTIBODY THERAPIES FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) |